Cargando…

Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets

The cells of the innate and adaptive immune systems have been implicated in the development of obesity-induced metaflammation and metabolic disorders including type 2 diabetes. Galectin-3, a β-galactoside-binding lectin, modulates immune/inflammatory responses and specifically binds to advanced glyc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pejnovic, Nada N, Pantic, Jelena M, Jovanovic, Ivan P, Radosavljevic, Gordana D, Djukic, Aleksandar Lj, Arsenijevic, Nebojsa N, Lukic, Miodrag L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774704/ https://www.ncbi.nlm.nih.gov/pubmed/24052904 http://dx.doi.org/10.4161/adip.24881

Ejemplares similares

Galectin-3 Deficiency Accelerates High-Fat Diet–Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
por: Pejnovic, Nada N., et al.
Publicado: (2013)

IL-33/ST2 axis in innate and acquired immunity to tumors
por: Jovanovic, Ivan P., et al.
Publicado: (2012)

Overexpression of Galectin 3 in Pancreatic β Cells Amplifies β-Cell Apoptosis and Islet Inflammation in Type-2 Diabetes in Mice
por: Petrovic, Ivica, et al.
Publicado: (2020)

Differential Immunometabolic Phenotype in Th1 and Th2 Dominant Mouse Strains in Response to High-Fat Feeding
por: Jovicic, Nemanja, et al.
Publicado: (2015)

Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
por: Pejnovic, Nada, et al.
Publicado: (2016)

The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents
por: Pantic, Jelena M., et al.
Publicado: (2017)

Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017)

IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis
por: Babic, Zivan M., et al.
Publicado: (2018)

Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression
por: Jovanovic, Marina, et al.
Publicado: (2019)

Transgenic Overexpression of Galectin-3 in Pancreatic β Cells Attenuates Hyperglycemia in Mice: Synergistic Antidiabetic Effect With Exogenous IL-33
por: Jovicic, Nemanja, et al.
Publicado: (2021)

Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype
por: Milovanovic, Marija, et al.
Publicado: (2012)

Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma
por: Zdravkovic, Natasa D, et al.
Publicado: (2014)

Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
por: Pavlovic, Mladen, et al.
Publicado: (2018)

Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection
por: Stojanovic, Bojana, et al.
Publicado: (2019)

IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
por: Borovcanin, Milica M., et al.
Publicado: (2018)

Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma
por: Milosavljevic, Milos Z., et al.
Publicado: (2016)

ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
por: Jovanovic, Ivan, et al.
Publicado: (2011)

The organic ester O,O’-diethyl-(S,S)-ethylenediamine-N,N’-di-2-(3-cyclohexyl)propanoate dihydrochloride attenuates murine breast cancer growth and metastasis
por: Jurisevic, Milena, et al.
Publicado: (2018)

Galectin-3 in Inflammasome Activation and Primary Biliary Cholangitis Development
por: Arsenijevic, Aleksandar, et al.
Publicado: (2020)

The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo
por: Silconi, Zana Besser, et al.
Publicado: (2022)

Anemia of inflammation in patients with colorectal cancer: Correlation with interleukin-1, interleukin-33 and galectin-1
por: Jocić, Miodrag, et al.
Publicado: (2022)

Interleukin-17 in Chronic Inflammatory Neurological Diseases
por: Milovanovic, Jelena, et al.
Publicado: (2020)

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021)

Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients
por: Lukic, Ruzica, et al.
Publicado: (2017)

Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice
por: Arsenijevic, Aleksandar, et al.
Publicado: (2019)

The Pivotal Role of Galectin-3 in Viral Infection: A Multifaceted Player in Host–Pathogen Interactions
por: Stojanovic, Bojana S., et al.
Publicado: (2023)

Galectin-3 as an important prognostic marker for COVID-19 severity
por: Gajovic, Nevena, et al.
Publicado: (2023)

Galectin-3’s Complex Interactions in Pancreatic Ductal Adenocarcinoma: From Cellular Signaling to Therapeutic Potential
por: Dimitrijevic Stojanovic, Milica, et al.
Publicado: (2023)

Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
por: Volarevic, Vladislav, et al.
Publicado: (2011)

Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens
por: Arsenijevic, Aleksandar, et al.
Publicado: (2016)

Galectin-1 as the new player in staging and prognosis of COVID-19
por: Markovic, Sofija Sekulic, et al.
Publicado: (2022)

Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice
por: Milovanovic, Jelena, et al.
Publicado: (2017)

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
por: Jovanovic, Milan, et al.
Publicado: (2018)

Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
por: Minic Janicijevic, Slavica, et al.
Publicado: (2022)

Mesenchymal Stem Cells Attenuate Cisplatin-Induced Nephrotoxicity in iNOS-Dependent Manner
por: Simovic Markovic, Bojana, et al.
Publicado: (2017)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Pharmacological Inhibition of Gal-3 in Mesenchymal Stem Cells Enhances Their Capacity to Promote Alternative Activation of Macrophages in Dextran Sulphate Sodium-Induced Colitis
por: Simovic Markovic, Bojana, et al.
Publicado: (2016)

Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior
por: Srejovic, Ivan, et al.
Publicado: (2020)

The Expression of IL-1β Correlates with the Expression of Galectin-3 in the Tissue at the Maternal–Fetal Interface during the Term and Preterm Labor
por: Jovic, Nikola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ce5mkofh20t6a7hkt5k59ppg0